Idorsia Ltd. (OTC:IDRSF) Financings
Financings
| Raise | Date | In US dollars |
|---|---|---|
| New Notes of Idorsia Investments SARL with 12% earn-out Announced: CHF 72M Use of proceeds: Launch capital for TRYVIO/JERAYGO: a focused US launch and phased commercialization in Europe and Canada | Oct 29, 2026 | US$86.78M |
| Private placement of registered shares (new and treasury shares) Closed: CHF 65.6M raised · CHF 4 a share Buyers: Jean-Paul and Martine Clozel (Offer Shares for an aggregate amount of up to CHF 10 million) Insiders: Founding shareholders Jean-Paul and Martine Clozel committed to buy Offer Shares at the offer price for up to CHF 10 million, with a 180-day lockup Use of proceeds: Strengthen balance sheet, accelerate QUVIVIQ commercial trajectory, advance pipeline, and general corporate purposes | Oct 10, 2025 | US$81.69M |
| Shares (equity line) Update: raise Use of proceeds: To further extend the cash runway into 2027 | Aug 27, 2025 | |
| New money facility Update: CHF 150M · Warrants at CHF 1.5 Use of proceeds: Extend cash runway to mid-2026 | May 21, 2025 | US$181.85M |
| Private placement of shares Announced: private placement Use of proceeds: Additional capital to meet its obligations | Feb 26, 2025 |